TYMS and cancer: A related class of curcumin-5-FU hybrid pyrimidinediones was synthesized to merge thioredoxin reductase (TrxR) inhibition from curcumin with TS inhibition from 5-FU.121 The resulting compound 23 displayed strong selectivity toward A549 cancer cells and minimal toxicity against THLE normal cells.